Category: St. Jude Medical
St. Jude Medical CEO Daniel Starks tells analysts that the medical device company doesn't need to follow it's competitors down the path of consolidation.
St. Jude Medical's 4th-quarter and 2014 profits surge as its sales and earnings meet expectations on Wall Street.
The FDA approves St. Jude Medical's FlexAbility ablation catheter for treating cardiac fibrillation.
St. Jude Medical reports 'solid and uncontroversial' preliminary 4th-quarter sales of $1.44 billion despite setbacks with its Portico replacement heart valve.
St. Jude Medical launches a clinical trial to evaluate the use of ablation and cardiac rhythm management devices in treating ventricular tachycardia.
Google Ventures, the VC arm of the Silicon Valley tech monolith, pumped more than ⅓ of its venture spend into healthcare and life science startups during 2014.
Google (NSDQ:GOOG) took a bigger bet on healthcare in 2014, investing more than ⅓ of the its venture dollars in healthcare and life science interests, according to the company and published reports.